SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-20-002039
Filing Date
2020-05-11
Accepted
2020-05-11 16:15:31
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4381
  Complete submission text file 0000902664-20-002039.txt   5863
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MATRIX CAPITAL MANAGEMENT CO., LP 1000 WINTER STREET, SUITE 4500 WALTHAM MA 02451
Business Address
GOEL DAVID E. (Reporting) CIK: 0001548144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38957 | Film No.: 20864960